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Background: An adolescent with a chronic condition must prepare for transition from the pediatric to the adult health
care system. Ideally, transition is a purposeful and coordinated process between the two systems. We sought to
evaluate a pediatric rheumatology transition clinic from the perspective of the young adults who attended the clinic.
Methods: Young adults who attended the IWK Health Centre Pediatric Rheumatology Transition Clinic in Halifax, Nova
Scotia, Canada were asked to complete a mail questionnaire. In this clinic an adult rheumatologist joins the pediatric
team for the patient’s visit. Subjects rated satisfaction with the clinic and how completely a number of items were
addressed (e.g. knowledge about disease, self-management, adolescent issues) on a 10 cm visual analog scale (higher
scores reflecting more favourable assessment). Compliance with follow-up post-transfer to adult care was assessed by
self-report and a chart review. Data were summarized descriptively.
Results: The response rate was 34 % (51/151). The mean age of respondents was 22 years with the majority diagnosed
with juvenile idiopathic arthritis. Most patients were transferred to adult care between the ages of 17 and 20 years. The
mean overall satisfaction score with the transition clinic was 7.3 ± 2.6. There was significant variability regarding how
well individual transition-related items were perceived to have been addressed, with an overall mean of 6.1 ± 3.2. Items
which received a majority of scores of > 7 included learning about side effects of medications, learning to live with their
disease, confidence in disease management, and control of disease at transfer. Items rated as <5 by a third of respon-
dents included addressing teen issues (smoking, alcohol, sexual health) and learning about new developments related
to their condition. 74 % of patients reported regular appointments with adult rheumatology.
Conclusions: Most young adults reported overall satisfaction with the transition clinic, however their perception of
how adequately various transition issues were addressed was quite variable. It appears that there were some perceived
deficits in the care that was provided in all areas, but possibly more so in counselling around general adolescent issues.
There was a high rate of follow-up after transfer to the local adult clinic.
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Adolescence is the period of transition from a dependent
child to an independent adult. This normal developmental
process includes changes in cognition from concrete to
abstract thinking, moving towards increasing autonomy,
identification of peer groups, as well as emotional, physical,
and sexual development [1]. Chronic illness can affect an
adolescent’s development in a number of ways including* Correspondence: Elizabeth.stringer@iwk.nshealth.ca
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creativecommons.org/publicdomain/zero/1.0/frequent and/or prolonged hospitalizations taking the youth
out of school and away from peers, illness-related physical
limitations, changes in physical appearance, and the natural
tendency of families and health care providers to shelter a
youth with a chronic disease [2]. In addition, some adoles-
cents with a chronic illness may exhibit behaviors and atti-
tudes that negatively impact a previously well-managed
condition [3]. Taken altogether, adolescence can be a chal-
lenging period for youth with chronic illness, their families
and their health care providers.
Adolescents with a chronic disease and their families
must prepare for the transition from pediatric healtharticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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tion is becoming increasingly recognized as an important
area for clinicians, researchers, and policy-makers to
address [4–9]. While acknowledging the need for more evi-
dence, a number of position statements have been pub-
lished outlining the fundamental principles of transition
with one key message being that it should be a purposeful,
organized, and coordinated process involving the youth,
family and the health care team, with the goal of optimizing
health and facilitating each young person’s attainment of
their potential as they move into adulthood [4–9].
There is some evidence that morbidity increases in
young adults once they transfer to adult care. Nakhla
et al. found that diabetes-related hospitalizations in-
creased in the 2 years after transfer compared with the
2 years before [10]. A study of children with renal trans-
plants found that 35 % of grafts were lost following
transfer to adult care with a median time to graft loss of
12 months, having had stable renal parameters for the
12 months before transfer [11]. The authors hypothe-
sized that medication adherence played a significant role
in graft loss. In a population of children with rheumatic
diseases, active disease and disease flares were found to
be high at the time of transfer [12]. Missed appoint-
ments can also be a problem in the transfer period [13].
In an effort to improve the transition process and
ultimately the outcome of young adults with childhood-
onset chronic diseases, specific clinics dedicated to facili-
tating the transition process have been developed in a
number of centers. To date there has been minimal for-
mal evaluation of these clinics. The aim of this study
was to evaluate a pediatric rheumatology transition
clinic. We modeled the transition clinic based on previ-
ously gathered information from adolescents and parents
in our clinic regarding their views on transition and their
perceived health care needs during transition [14]. We
assessed outcomes related to education and daily func-
tioning in patients who had attended our pediatric
rheumatology transition clinic, and ascertained satisfac-
tion with the transition process as well as the rate of
follow-up in the adult clinic.
Methods
The Pediatric Rheumatology Transition clinic at the
IWK Health Centre, a children’s tertiary hospital in
Halifax, Nova Scotia, Canada, began in 1994. It is a dedi-
cated clinic for adolescents with chronic rheumatic dis-
eases in the transition period and is held three to six
times per year. The clinic takes place in the pediatric
rheumatology clinic and is attended by at least one
pediatric rheumatologist, an adult rheumatologist with
an interest in youth, a pediatric rheumatology nurse, and
a pediatric physiotherapist. Generally, we attempt to
transfer patients when they have finished high schooland their disease is quiescent, therefore the first transi-
tion clinic appointment usually occurs in the 2 years
prior to completion of high school. The timing and
number of scheduled transition clinic visits before trans-
fer to the adult system is individualized for each patient
based on our assessment of need, both from a medical
and psychosocial point of view. We do not limit discus-
sions around transition to transition clinics; it is our
practice to begin addressing these issues much earlier
during regular clinic appointments, however, the transi-
tion clinics are dedicated to the older teen group (e.g.
younger children are not seen during this clinic) and
transition/impending transfer is the primary focus of the
health care team. At the first transition clinic visit, the
adolescent is seen in consultation by the adult rheuma-
tologist who reviews their case with their pediatric
rheumatologist. Both physicians complete the assess-
ment together with the patient, and other members of
the pediatric rheumatology team assess the adolescent as
needed to discuss transition issues. It is standard prac-
tice to see the patient alone, with the parent joining at
the end of the visit. During follow up visits, either the
adult or pediatric rheumatologist does the primary as-
sessment, followed by both physicians seeing the patient
to discuss management and transition plans, and mem-
bers of the allied health pediatric team addressing transi-
tion issues. Depending on disease activity, adolescents
may be seen in the pediatric rheumatology clinic for
regular care by the pediatric team between transition
clinic appointments. The transition clinic serves patients
from the three Maritime Provinces. The majority of pa-
tients who live locally are transferred to the adult
rheumatologist who attends the transition clinic, while
most other patients are transitioned to rheumatologists
in their region.
In 2003, questionnaires were mailed to 151 patients
who had attended or were currently attending the transi-
tion clinic. The questionnaire included demographic
data, diagnosis, and whether respondents had ongoing
adult rheumatologic care. The charts of all the patients
transferred to the adult rheumatologist attending the
transition clinic were reviewed to assess patient compli-
ance with follow-up. Respondents were asked to rate
their overall satisfaction with the transition clinic using a
10 cm visual analog scale (VAS) (anchored at 0 with
“completely unsatisfied” and at 10 with “completely sat-
isfied”). They also indicated how well specific items re-
lated to the transition process were addressed (anchored
at 0 with “not at all” to 10 with “addressed completely”).
The items included in the survey included those that
would be included in an adolescent health assessment
and transition-specific items, specifically those that
would impact on independent health behaviors and self-
advocacy [4, 15]. To characterize the sample, health
Table 1 Demographic characteristics of subjects
Demographic variable Result





No response 1 (2.0)
Diagnosis, n (%)
Juvenile idiopathic arthritis 42 (82.3)
Systemic lupus erythematosus 4 (7.8)
Juvenile dermatomyositis 1 (2.0)
Other 4 (7.8)
Province of residence, n (%)
Nova Scotia 42 (82.3)
New Brunswick 7 (13.7)
Prince Edward Island 2 (3.9)




Highest Educational level, n (%)
Completed High school 16 (31.4)
Community collegea 5 (9.8)
University undergraduatea 24 (47.1)
University postgraduatea 1 (2.0)
No response 5 (9.8)
Smoke >10 cigarettes daily, n (%) 7 (13.7)
Use alcohol at least once per month over past year, n (%) 26 (51.0)
Sexually active, n (%) 41 (80.3)
aCompleted or enrolled
Stringer et al. Pediatric Rheumatology  (2015) 13:22 Page 3 of 7status and quality of life were assessed by two well-
validated measures, the Medical Outcomes Study 36 item
Short Form (SF-36), and the Stanford Health Assessment
Questionnaire (HAQ) measured arthritis-specific func-
tional disability [16, 17]. The SF-36 comprises 36 items in
8 domains: physical functioning, role physical, bodily pain,
general health perceptions, energy and vitality, social func-
tioning, role emotional, and mental health. Domain scores
range from 0 to 100 with higher scores reflecting more
normal function. The HAQ consists of 19 items in 9 do-
mains: dressing and grooming, arising, eating, walking, hy-
giene, reach, grip, activity and sexual function. Scores of 0
to 1 are generally considered to represent mild to moder-
ate difficulty, 1 to 2 moderate to severe disability, and 2 to
3 severe to very severe disability.
The data were collated and descriptive data analysis
was performed using Microsoft®Excel ® 2008 for Mac,
Version 12.3.6. When analyzing satisfaction and how
well items were addressed we elected to define high as >
7, moderate as 5–7, and poor as <5 on the 10 cm VAS
scale. SF-36 scores were compared with age-matched
norms determining how many scores were more than 1
and 2 SDs below the mean for each domain [16]. The
median values of the transition clinic overall satisfaction
scores, the perception of disease-control at transfer,
HAQ scores and general health perception scores of the
SF-36 were compared between those subjects who re-
ported regular follow-up in adult rheumatology care and
those who reported no regular follow-up using Stata®
v11.1, 2009. This study was approved by the IWK Health
Centre Research Ethics Board.
Results
Fifty-one completed questionnaires were returned giving
a response rate of 34 %. Demographic data are presented
in Table 1. The median age at the time of questionnaire
completion was 22.0 years (range 17 to 27 years). The
most common condition was JIA (82 %). The majority of
respondents resided in Nova Scotia (82 %). Of the 46 re-
spondents who answered questions on educational level,
16 completed only high school, and of the remaining, 5
completed or were enrolled in community college, 24
completed or were enrolled in a university undergradu-
ate program, and one was enrolled in a university post-
graduate program. Fourteen percent of respondents
reported being regular smokers (>10 cigarettes per day),
51 % reported alcohol use at least once per month over
the past year, and 80 % reported being sexually active.
Most patients (88 %) were transitioned between 17
and 20 years of age. Five patients were transferred at the
age of 16. Twenty-nine of 50 respondents (58 %) felt
they were transitioned at the appropriate age, whereas 6
(12 %) felt they were too young and 3 (6 %) felt they
were too old (all of these subjects were transferredbetween 17 and 20 years of age). Twelve respondents
(24 %) felt age did not matter. Of 40 patients who indi-
cated the number of transition clinics they had attended,
17 subjects (43 %) attended a single transition clinic
prior to transfer, 18 (45 %) attended 2 to 4, and 5 (12 %)
attended five or more. Of 47 patients responding to the
question regarding the appropriate number of transition
clinics, 26 (55 %) felt they attended the appropriate
number of transition clinics. Fourteen of these subjects
(54 %) had attended 2 to 4 clinics and 7 (27 %) had
attended only a single transition clinic. Of the 9 subjects
who felt they attended too few clinics, 7 (78 %) had
attended only one clinic. One patient felt they attended
too many clinics and 11 respondents felt it didn’t matter
how many transition clinics they attended.
Quality of life data, as assessed using the SF-36, are
presented in Table 2. There were impairments in all
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scoring greater than 2 standard deviations below the
mean in 5 out of 8 domains, including physical function-
ing, role physical, bodily pain, social functioning and
mental health. The median score on the HAQ disability
index was 0.125 representing mild disability (range 0 to
1.5). Twenty-six (51 %) respondents had a HAQ score of
zero, representing no or minimal disability while 25
(49 %) had a score greater than zero, representing some
degree of disability. Of these, 5 subjects (9.8 %) had a
score of 1 to 1.5 indicating moderate disability. All re-
spondents answered questions on how much they had
reduced their daily activities because of their health over
the previous six months. Twenty-eight respondents
(55 %) reported having reduced their activities on an
average 27 days over the past 6 months (range 1 day to
everyday). Nine respondents (19 %) were completely un-
able to carry out their activities on an average of 3.8 days
(range 1 to 15 days). Seventeen respondents (44 %) had
missed work on an average of 3.3 days (range 1 to 7 days)
and 13 (33 %) were unable to complete all their work-
related activities on an average of 2.7 days (range 1 to
5 days).
Overall satisfaction with the transition clinic and rat-
ings of how well individual items related to the transi-
tion process were addressed in the clinic are found in
Table 3. The mean satisfaction score with the transition
clinic, as measured on a 10 cm VAS, was 7.3 (SD 2.6).
Thirty patients (59 %) rated overall satisfaction >7. The
mean scores of how well items were addressed ranged
from 4.9 to 7.6 out of 10 (mean 6.1). For a number of
items, some respondents rated the item as high (>7) and
an equal or close to equal number rated the item as poor
(<5). One example is the item in which subjects felt in-
volved in decision-making; 45 % rated this in the high
satisfaction range (>7) and 29 % rated this in the poor
satisfaction range (<5). Four of the 14 specific items
assessed were given a rating of >7 by the majority ofTable 2 Quality of life (SF-36) of subjects and comparison with
normative data for 18 to 25 year olds
SF-36 Domain Median Range >1 SD (%) >2 SD (%)
Physical functioning 90 17-100 15 (29) 10 (20)
Role physical 100 0-100 19 (37) 14 (27)
Bodily pain 100 0-100 14 (27) 14 (27)
General health perceptions 75 25-100 13 (25) 4 (8)
Energy and vitality 62 10-100 15 (29) 4 (8)
Social functioning 60 0-100 29 (57) 14 (27)
Role emotional 72 12-100 7 (14) 1 (2)
Mental health 62 10-100 20 (39) 14 (27)
> 1 SD is number of patients more than 1 standard deviation below the
population mean; > 2 SD is number of patients more than 2 standard
deviations below the population meansubjects: learned about side effects of medications
(51 %), learned about future living with their disease
(53 %), felt confident in disease management (53 %), and
disease well-controlled at transfer (53 %). However, even
within these items, a proportion of respondents rated
the item in the poor range (<5). Five items had at least a
third of respondents scoring poorly (<5): smoking ad-
equately addressed (33 %), alcohol use adequately ad-
dressed (35 %), drug use adequately addressed (33 %),
sexual health adequately addressed (33 %), and learned
about new developments related to their disease (45 %).
Again, although these 4 items had the highest propor-
tion of low scores, some subjects rated the same item in
the high range. Five items appeared to be distributed
more evenly: felt well-informed as a patient, learned to
manage a disease flare, learned to manage pain, felt in-
volved in decision-making, and learned about joint
protection.
Thirty-seven out of fifty (74 %) respondents reported
having regular appointments with an adult rheumatolo-
gist, whereas the others reported not attending regular
appointments. There were no differences between these
two groups when comparing the overall transition clinic
satisfaction score, the perception of how well disease
was controlled at transfer, HAQ score and general health
perception score of the SF-36 (Table 4). All of those
reporting no regular follow-up had been transferred to
adult rheumatologists other than the individual involved
with the transition clinic. Eight of these patients had JIA,
2 had SLE, and 3 had “other” rheumatic conditions.
When office charts of the adult rheumatologist who par-
ticipates in the transition clinic were reviewed, 92 % of
patients had attended all or most of their follow-up ap-
pointments in the adult clinic.
Discussion
A number of studies have described various transition
processes and explored the transition needs of adoles-
cents with a chronic illness and their families. Most de-
scriptions are confined to specific health conditions
within a subspeciality clinic such as our own [18]. There
are a number of position statements and guidelines to
aid health care providers in delivering the best care to
this patient population [6, 8]. We drew upon these re-
sources as well as information obtained from our previ-
ous work when we developed our transition clinic [14].
There has been much less research evaluating transition
clinics, making the current study an important contribu-
tion to the literature.
The majority of respondents in our study were Caucasian
females with JIA, which is consistent with the makeup of
the clinic population. Of the 90 % responding to questions
about education, all had completed high school and 65 %
were enrolled in or had completed post-secondary
Table 3 Satisfaction with the transition clinic measured on a 10 cm VAS






Overall satisfaction with transition clinic 7.3 ± 2.6 (0.1-10) 30 (59) 9 (18) 8 (16)
Smoking was adequately addressed 5.6 ± 3.8 (0–10) 20 (39) 7 (14) 17 (33)
Alcohol use was adequately addressed 6.0 ± 3.6 (0–10) 23 (45) 6 (12) 18 (35)
Drug use was adequately addressed 5.8 ± 4.0 (0–10) 24 (47) 6 (12) 17 (33)
Sexual health was adequately addressed 5.9 ± 3.6 (0–10) 22 (43) 8 (16) 17 (33)
Felt well-informed as a patient 6.5 ± 2.8 (0.8-10) 23 (45) 12 (24) 12 (24)
Learned to manage a disease flare 6.1 ± 3.0 (0.1-10) 20 (39) 13 (26) 14 (28)
Learned to manage pain 6.4 ± 2.7 (0.2-10) 18 (35) 12 (24) 10 (20)
Learned about joint protection 5.7 ± 3.3 (0–10) 16 (31) 11 (22) 14 (28)
Learned about new developments 4.9 ± 3.3 (0–10) 15 (29) 9 (18) 23 (45)
Learned about side effects of medications 6.3 ± 3.2 (0–10) 26 (51) 9 (18) 12 (24)
Learned about future living with their disease 5.9 ± 3.2 (0–10) 27 (53) 4 (8) 16 (31)
Felt involved in decision-making 6.1 ± 3.1 (0–10) 23 (45) 9 (18) 15 (29)
Felt confident in disease management 6.9 ± 3.1 (0.2-10) 27 (53) 8 (16) 11 (22)
Disease was well-controlled at transfer 7.6 ± 2.7 (0.1-10) 34 (67) 6 (12) 6 (12)
aPercentages per item do not add up to 100 due to incomplete fields by subjects
Stringer et al. Pediatric Rheumatology  (2015) 13:22 Page 5 of 7education. Canadian census data from 2006 indicate that
79.5 % of males and 83 % of females in Nova Scotia attain
at least a high-school education [19]. Considering the age
range of our subjects, our findings are consistent with pre-
vious studies suggesting that young adults with JIA fare at
least as well as the general population in terms of educa-
tional outcomes [20]. A number of subjects demonstrated
poorer health-related quality of life when compared with
population norms, and half had some degree of disability
as demonstrated by the HAQ. The functional outcome of
our patient population is comparable with findings re-
ported in a recent review of adult outcomes of patients
with JIA, where approximately 40 % of young adults are
somewhat limited in their functional capacity and 10 % are
in need of assistance to manage daily routines [21].
Most respondents in our study reported overall satis-
faction with the transition clinic, with a mean of 7.3 on
the VAS. It appears, however, that some individual items
are better addressed than others, and in general there is
room for improvement, as all items received a propor-
tion of poor ratings (<5 on the VAS). Items relatedTable 4 Comparison of subjects reporting regular follow-up with ad
with adult rheumatology care
Variable Regular follow-up median score
Overall satisfaction with transition clinic 8.6
Disease well-controlled at transfer 8.4
HAQ score 0.125
SF-36 general health perceptions 57
*Mann–Whitney U Testdirectly to their disease, such as learning about side ef-
fects of medications and confidence in disease manage-
ment, were reported to have been more completely
addressed. There are a number of potential reasons for
higher satisfaction in these domains. Many patients were
diagnosed as young children and would have had many
years to become familiar with their disease and treat-
ments prior to the transition period. Secondly, our previ-
ous research indicated that one of the most important
factors for adolescents in determining readiness for
transfer was confidence in managing their disease. This
would therefore likely have been a major focus of the
health care providers in the clinic. Our findings are simi-
lar to those of McDonagh et al. in which adolescents
and young adults felt that assuming primary responsibil-
ity in managing their health-care was an essential part of
transition [22]. In addition, it is likely that our practice
of seeing patients independently of their parents contrib-
uted positively to overall confidence in self-management.
The highest scoring item was satisfaction with disease-
control at transfer, suggesting that our practice of delayingult rheumatology care and those reporting no regular follow-up





Stringer et al. Pediatric Rheumatology  (2015) 13:22 Page 6 of 7transfer of patients if there is evidence of uncontrolled dis-
ease should be continued whenever possible.
Items in which a third of respondents provided a poor
rating of the item being adequately addressed (<5 on the
VAS) included disease non-specific items: addressing
smoking, alcohol, drugs and sexual health. These poorer
scores may be due to lack of discussion around these
topics or that these items were addressed in a manner
that was not optimal for the patient, or a combination of
both. It is important to note that many respondents also
rated the same items in the higher range (>7 on the
VAS). There are different views regarding the perceived
importance and desire to discuss items such as these de-
pending on who is asked. In our previous survey of pa-
tients of a similar age, we found that only a third felt
that it was important to discuss these issues; similar
findings were reported in a study of adolescents with
cystic fibrosis [14, 23] Perhaps not surprisingly, however,
most parents surveyed in our previous study felt there
was a need for education around these topics. The Soci-
ety for Adolescent Medicine’s position paper on transi-
tion states the importance of addressing topics such as
sexuality and substance use in transitional health pro-
grams [7]. Similarly, as health care providers, we feel
that discussion around these issues is critical given the
potential toxicities of medications in youth who have a
high likelihood of using alcohol and are likely to be
sexually active. Developing methods that will effectively
address these issues during the transition process is an
important area and deserves further appraisal and study.
Another poorly rated item was learning about new de-
velopments in their condition, with a mean score of 4.9/
10. Our previous work demonstrated this to be the high-
est perceived educational need of adolescents, highlight-
ing a deficit in our care and the importance of improved
knowledge translation initiatives. This need and how
best to address it deserves further exploration.
In our clinic, 88 % percent of patients were transferred
between 17 and 20 years of age, and most felt this was
appropriate. A small number of individuals, all 17–20
years of age, felt they were either too young or too old at
transfer. Our approach, which allows individualizing the
time of transfer, appears satisfactory to most patients.
From a health systems point of view this is noteworthy
as it relies on an institution’s policy to allow patients to
be followed beyond age 16 if they have a chronic illness.
Most respondents felt that they had attended the appro-
priate number of clinics; in most cases this was between
two to four. Our present model is constrained by the
number of times the adult rheumatologist is able to at-
tend a combined clinic at the pediatric hospital. Seven of
the 9 respondents who reported attending too few tran-
sition clinics had attended only one. There may be a role
for involving patients in the decision-making processregarding the number of transition clinics to be attended
prior to transfer in the future.
An alternative model of transition is to have a young
adult clinic that is a stepping-stone between pediatric
and adult care. A number of centres in Canada have de-
veloped clinics for Young Adults with Rheumatic Dis-
eases (YARD clinics) in which young adults are seen in a
clinic specifically for youth aged 18 to 25 [24]. Further
work to evaluate the effectiveness of different models of
transition-related care will be important in order to in-
form clinicians and administrators regarding the best
and most cost-efficient care-model for this population.
Approximately 25 % of respondents in our study re-
ported no regular follow-up by an adult rheumatologist,
comparable to the study by Hersh et al. in which 30 %
of subjects missed their first scheduled adult rheumatol-
ogy appointment and the rate of missed appointments in
the post-transfer period was 21 % [12]. It is important to
note that all of the respondents reporting no follow-up
in our study were those transferred to other rheumatolo-
gists (i.e. not the adult rheumatologist involved in the
transition clinic), whereas almost all patients followed
up by the adult rheumatologist in the transition clinic
attended all or most of their appointments, as confirmed
by chart audit. This suggests that continuity of care may
be an important factor in achieving improved adherence
to follow-up after transfer.
This study has a number of limitations. The response
rate from our study was only 34 %, leading to limited
statistical power and potentially leading to selection bias.
Secondly, our primary outcomes were satisfaction and
rating of the completeness of care. Satisfaction and com-
pleteness of care are complex constructs; we were not
aware of a validated measure of satisfaction that would
apply to our study population, therefore we chose to use
a 10 cm VAS to measure these outcomes. While this
provides us with useful information regarding perceived
gaps in care, there are likely limitations to this method
of measurement and importantly our study does not ad-
dress whether these outcomes correlate with other out-
comes such as knowledge acquisition, self-management
behaviours or disease outcomes. It also does not provide
information regarding how items could be better ad-
dressed. Finally, our questionnaire did not address percep-
tions regarding completeness of addressing psychosocial
and mental health concerns in the transition clinic, an area
which we feel needs future study.
Conclusion
This study describes satisfaction with the transition ex-
perience of young adult rheumatology patients after
transfer to adult care. Most reported overall satisfaction
with the transition clinic, and most respondents felt that
being transferred between 17 and 20 years of age was
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equately various transition issues were addressed was
highly variable. Future research should explore patient
preferences regarding discussions around substance use
and sexual health in particular, and should aim to im-
prove knowledge translation to provide adolescents with
information on new developments related to their ill-
ness. Our study reports a high follow-up rate in adult
care for a subset of patients attending a rheumatology
transition clinic. We speculate that this may be in part
related to the continuity of care provided by our joint
pediatric-adult clinic transition model. Improving the
transition process for those patients transferred to adult
rheumatologists other than the specific adult rheuma-
tologist attending the clinic should be a priority for fu-
ture transition work at our institution, as these patients
appear to be at higher risk of being lost to follow-up.
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